Firm Analyst
Bank of America Merrill Lynch   Steve Byrne
Barclays Capital   Jim Birchenough
Boenning & Scattergood   Derek Jellinek
Credit Suisse   Ying Huang
Needham   Mark Monane
Piper Jaffray   Edward A. Tenthoff
RBC Capital Markets   Michael Yee
Robert W. Baird & Co   Christopher J. Raymond
Roth Capital Partners   Joe Pantginis
Standard & Poors   Steven Silver
ThinkEquity   Brian Skorney

Regeneron Pharmaceuticals, Inc. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Regeneron Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Regeneron Pharmaceuticals, Inc. or its management. Regeneron Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Print Print page     Email Email page

Stock Information

NASDAQ:REGN
$23.28   + 0.80
Sep 2, 2010
11:32 AM ET
Quotes delay at least 20min., by eSignal.
Stock price graph
3 Mo.   6 Mo.   1 Yr.

Shareholder Tools

Featured Report